PIPE-791
Sponsors
Contineum Therapeutics Inc., Contineum Therapeutics
Conditions
Chronic Low Back PainChronic Osteoarthritis PainHealthyHealthy VolunteersIdiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)Multiple SclerosisMultiple Sclerosis, MS
Phase 1
Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of PIPE-791 and Food Effect in Healthy Volunteers
CompletedNCT05983939
Start: 2023-06-26End: 2024-02-01Updated: 2024-02-14
PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF
CompletedNCT06683612
Start: 2024-12-09End: 2025-06-12Updated: 2025-08-06
Study of PIPE-791 for Subjects With Chronic Osteoarthritis Pain or Chronic Low Back Pain
CompletedNCT06810245
Start: 2025-02-04End: 2026-01-20Updated: 2026-03-18